Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
This COVID-19 roundup includes a summary of studies on the effective treatment options for patients with long COVID, the risk of patients developing medical or mental health conditions post-hospitalization...
Many pediatric patients who are recommended to receive two doses of the influenza vaccine do not receive both doses, despite vaccinations being associated with a significant decrease in the risk of...
The updates and recommendations by the CDC and several organizations include the addition of the COVID-19 vaccine for pediatric patients and a new pneumococcal conjugate vaccine.
This COVID-19 roundup includes coverage of the FDA’s modification of bivalent vaccines in infants aged 6 months, the NIH advises against the use of bebtelovimab, and impact COVID-19 has on short-term...
This COVID-19 roundup includes coverage of the FDA’s recent approval of bivalent booster vaccines for younger age groups, the use of COVID-19 PrEP and associated risk for the virus, an increase of...
Despite most pertussis cases occurring in infants aged 2 months or younger, this patient population is too young to receive the childhood pertussis vaccine series. The approval of the pertussis vaccine...
An updated report for the use of the influenza vaccine and antiviral medications has been released from the American Academy of Pediatrics for the 2022-2023 influenza season.
